Altimmune’s pemvidutide shows promising Phase IIb MASH results; see key benefits, risks, and a bullish outlook. Read here for ...

The general mood among these heavyweight investors is divided, with 22% leaning bullish and 59% bearish. Among these notable ...

In 2025, the battle between tangible and digital stores of value is no longer binary. Gold remains the primary refuge in crisis; Bitcoin serves as the agile, higher-beta hedge when conditions ease.

OppFi is focused on non-prime consumer installment loans, showing strong double-digit revenue and EPS growth. Read why OPFI stock is a Hold.

Before diving into trading options with real money, a good first step for both novice and experienced traders is to practice their strategies and familiarize themselves with the platform they choose ...

A synthetic short strategy allows investors to simulate risk/reward Savvy traders know that selling a stock short isn't without its downsides. Namely, you have to borrow shares from a broker. However, ...

YieldMax™ PYPL Option Income Strategy ETF (NYSEARCA:PYPY) declares $0.0883/share weekly dividend. Payable Oct. 24; for shareholders of record Oct. 23; ex-div Oct. 23. See PYPY Dividend Scorecard, ...

Operating as an investment proxy for the cryptocurrency market, Strategy ($MSTR) represents a highly “popular” enterprise in ...

Running the latter miles of a marathon can sometimes feel unbearable. I experienced that first-hand earlier in October during the last seven miles or so of the Chicago Marathon, running on fumes and ...

NewAmsterdam Pharma (NAMS) continues to operate at a loss, with reported losses growing at an average rate of 52% per year over the past five years. Despite the lack of profitability and no signs of ...